Cargando…
AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG
Primary open‐angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increased endothelin‐1 (ET‐1) has been observed in aqueous humour (AH) of POAG patients, resulting in an increase in the out‐flow resistance of the AH. However, the underlining mechanisms remain elusi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131939/ https://www.ncbi.nlm.nih.gov/pubmed/32052937 http://dx.doi.org/10.1111/jcmm.15032 |
_version_ | 1783517348052860928 |
---|---|
author | Zhao, Yingying Zhu, Huazhang Yang, Yangfan Ye, Yiming Yao, Youli Huang, Xiaoyan Zhang, Yixiang Shu, Xingsheng Chen, Xianxiong Yang, Yatao Ma, Junxian Cheng, Le Wang, Xiaomei Ying, Ying |
author_facet | Zhao, Yingying Zhu, Huazhang Yang, Yangfan Ye, Yiming Yao, Youli Huang, Xiaoyan Zhang, Yixiang Shu, Xingsheng Chen, Xianxiong Yang, Yatao Ma, Junxian Cheng, Le Wang, Xiaomei Ying, Ying |
author_sort | Zhao, Yingying |
collection | PubMed |
description | Primary open‐angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increased endothelin‐1 (ET‐1) has been observed in aqueous humour (AH) of POAG patients, resulting in an increase in the out‐flow resistance of the AH. However, the underlining mechanisms remain elusive. Using established in vivo and in vitro POAG models, we demonstrated that water channel Aquaporin 1 (AQP1) is down‐regulated in trabecular meshwork (TM) cells upon ET‐1 exposure, which causes a series of glaucomatous changes, including actin fibre reorganization, collagen production, extracellular matrix deposition and contractility alteration of TM cells. Ectopic expression of AQP1 can reverse ET‐1‐induced TM tissue remodelling, which requires the presence of β‐catenin. More importantly, we found that ET‐1‐induced AQP1 suppression is mediated by ATF4, a transcription factor of the unfolded protein response, which binds to the promoter of AQP1 and negatively regulates AQP1 transcription. Thus, we discovered a novel function of ATF4 in controlling the process of TM remodelling in ET‐1‐induced POAG through transcription suppression of AQP1. Our findings also detail a novel pathological mechanism and a potential therapeutic target for POAG. |
format | Online Article Text |
id | pubmed-7131939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71319392020-04-06 AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG Zhao, Yingying Zhu, Huazhang Yang, Yangfan Ye, Yiming Yao, Youli Huang, Xiaoyan Zhang, Yixiang Shu, Xingsheng Chen, Xianxiong Yang, Yatao Ma, Junxian Cheng, Le Wang, Xiaomei Ying, Ying J Cell Mol Med Original Articles Primary open‐angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increased endothelin‐1 (ET‐1) has been observed in aqueous humour (AH) of POAG patients, resulting in an increase in the out‐flow resistance of the AH. However, the underlining mechanisms remain elusive. Using established in vivo and in vitro POAG models, we demonstrated that water channel Aquaporin 1 (AQP1) is down‐regulated in trabecular meshwork (TM) cells upon ET‐1 exposure, which causes a series of glaucomatous changes, including actin fibre reorganization, collagen production, extracellular matrix deposition and contractility alteration of TM cells. Ectopic expression of AQP1 can reverse ET‐1‐induced TM tissue remodelling, which requires the presence of β‐catenin. More importantly, we found that ET‐1‐induced AQP1 suppression is mediated by ATF4, a transcription factor of the unfolded protein response, which binds to the promoter of AQP1 and negatively regulates AQP1 transcription. Thus, we discovered a novel function of ATF4 in controlling the process of TM remodelling in ET‐1‐induced POAG through transcription suppression of AQP1. Our findings also detail a novel pathological mechanism and a potential therapeutic target for POAG. John Wiley and Sons Inc. 2020-02-13 2020-03 /pmc/articles/PMC7131939/ /pubmed/32052937 http://dx.doi.org/10.1111/jcmm.15032 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Zhao, Yingying Zhu, Huazhang Yang, Yangfan Ye, Yiming Yao, Youli Huang, Xiaoyan Zhang, Yixiang Shu, Xingsheng Chen, Xianxiong Yang, Yatao Ma, Junxian Cheng, Le Wang, Xiaomei Ying, Ying AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title | AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title_full | AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title_fullStr | AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title_full_unstemmed | AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title_short | AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET‐1‐induced POAG |
title_sort | aqp1 suppression by atf4 triggers trabecular meshwork tissue remodelling in et‐1‐induced poag |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131939/ https://www.ncbi.nlm.nih.gov/pubmed/32052937 http://dx.doi.org/10.1111/jcmm.15032 |
work_keys_str_mv | AT zhaoyingying aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT zhuhuazhang aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT yangyangfan aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT yeyiming aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT yaoyouli aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT huangxiaoyan aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT zhangyixiang aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT shuxingsheng aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT chenxianxiong aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT yangyatao aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT majunxian aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT chengle aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT wangxiaomei aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag AT yingying aqp1suppressionbyatf4triggerstrabecularmeshworktissueremodellinginet1inducedpoag |